Literature DB >> 21317769

Left ventricular mechanical support with Impella provides more ventricular unloading in heart failure than extracorporeal membrane oxygenation.

Dai Kawashima1, Satoshi Gojo, Takashi Nishimura, Yoshihumi Itoda, Kazuo Kitahori, Noboru Motomura, Tetsuro Morota, Arata Murakami, Shinichi Takamoto, Shunei Kyo, Minoru Ono.   

Abstract

The Impella microaxial-flow pump can directly unload left ventricle (LV) in cases of acute heart failure. Extracorporeal membrane oxygenation (ECMO) is widely used for circulatory support. Although the clinical effectiveness of ECMO has been demonstrated, insufficient LV loading reduction may not be advantageous for myocardial recovery. The objective was to compare ventricular loading reduction and reversibility of ventricular fibrillation (VF) with either Impella or ECMO. Six dogs were used. Extracorporeal membrane oxygenation was established by the femoral artery and right atrium. The Impella LD was inserted in LV by the ascending aorta. An acute failing heart was created by sequential coronary artery ligations. Pressure-volume (PV) relationships were acquired without a device and with ECMO or Impella. When VF occurred, direct cardioversion was performed while supported by either ECMO or Impella. The PV area, which is a measure of ventricular unloading and is correlated with myocardial oxygen consumption, decreased more with Impella than with ECMO. Successful defibrillation was achieved more effectively while under Impella support. Superior ventricular unloading with the Impella device may provide higher recovery potential to damaged hearts than ECMO and may have a significant impact not only on intensive care of patients with heart failure but also on resuscitation.

Entities:  

Mesh:

Year:  2011        PMID: 21317769     DOI: 10.1097/MAT.0b013e31820e121c

Source DB:  PubMed          Journal:  ASAIO J        ISSN: 1058-2916            Impact factor:   2.872


  30 in total

1.  IABP plus ECMO-Is one and one more than two?

Authors:  Sebastian Nuding; Karl Werdan
Journal:  J Thorac Dis       Date:  2017-04       Impact factor: 2.895

2.  Percutaneous Mechanical Circulatory Support for Cardiogenic Shock.

Authors:  Kevin J Morine; Navin K Kapur
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-01

3.  [Treatment of cardiogenic shock complicating acute myocardial infarction].

Authors:  S Blazek; K Fengler; T Stiermaier; P Lurz; G Schuler; G Fürnau
Journal:  Herz       Date:  2014-09       Impact factor: 1.443

Review 4.  Management of acute heart failure in adult patients with congenital heart disease.

Authors:  Alexander Van De Bruaene; Lukas Meier; Walter Droogne; Pieter De Meester; Els Troost; Marc Gewillig; Werner Budts
Journal:  Heart Fail Rev       Date:  2018-01       Impact factor: 4.214

5.  The step forward for VA ECMO: left ventricular unloading!

Authors:  Paolo Meani; Federico Pappalardo
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

Review 6.  The evolution of temporary percutaneous mechanical circulatory support devices: a review of the options and evidence in cardiogenic shock.

Authors:  Freddy Abnousi; Celina Mei Yong; William Fearon; Dipanjan Banerjee
Journal:  Curr Cardiol Rep       Date:  2015-06       Impact factor: 2.931

7.  Left ventricular thrombus associated with arteriovenous extra corporeal membrane oxygenation.

Authors:  George Makdisi; Zubair A Hashmi; Thomas C Wozniak; I-Wen Wang
Journal:  J Thorac Dis       Date:  2015-11       Impact factor: 2.895

8.  Percutaneous Hemodynamic Support (Impella) in Patients with Advanced Heart Failure and/or Cardiogenic Shock Not Eligible to PROTECT II Trial.

Authors:  Wei Liu; Venkata Kishore Mukku; Syed Gilani; Ken Fujise; Alejandro Barbagelata
Journal:  Int J Angiol       Date:  2013-12

9.  The role of extracorporeal life support in acute myocarditis: a bridge to recovery?

Authors:  D Bradford Sanders; Steven R Sowell; Brigham Willis; John Lane; Christopher Pierce; Stephen Pophal; Francisco A Arabia; John J Nigro
Journal:  J Extra Corpor Technol       Date:  2012-12

10.  The trefoil protein TFF1 is bound to MUC5AC in human gastric mucosa.

Authors:  M-H Ruchaud-Sparagano; B R Westley; F E B May
Journal:  Cell Mol Life Sci       Date:  2004-08       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.